Navigation Links
Icahn Issues Statement Regarding Amylin Pharmaceuticals

NEW YORK, April 25, 2012 /PRNewswire/ -- Carl C. Icahn today announced that his affiliates had voluntarily dismissed their lawsuit against Amylin Pharmaceuticals which had sought an extension of the deadline to nominate directors at the 2012 annual meeting of shareholders. Mr. Icahn released the following statement:

The decision to discontinue our lawsuit seeking to extend the director nomination deadline was the result of discussions I had with Daniel Bradbury, Amylin's chief executive officer, that we agreed would not be publicly disclosed.

Mr. Icahn reiterated that he continues to strongly believe that the company should be sold at this time.

SOURCE Carl C. Icahn
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ADVENTRX Appoints Icahn Representative to Board of Directors
2. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
3. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
4. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
5. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
6. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
7. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
9. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
10. European Unions CHMP Issues Positive Opinion on Sugammadex
11. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
Post Your Comments:
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)... Va. , Nov. 30, 2015  IBA Molecular ... manufacture and distribution of radiopharmaceuticals, announced that as of ... Pharma, Inc. (Zevacor Pharma). The decision to rebrand the ... the firm as well as its close relationship with ... by Illinois Health and Science (IHS). ...
(Date:11/30/2015)... , Nov. 30, 2015 Baxalta ... biopharmaceutical leader dedicated to delivering transformative therapies ... medical conditions, today announced the launch and ... PEGylated], an extended circulating half-life recombinant factor ... on full-length ADVATE [Antihemophilic Factor (Recombinant)]. The ...
Breaking Medicine Technology:
(Date:11/30/2015)... BALTIMORE, Md. (PRWEB) , ... November 30, 2015 ... ... be rewarding, but also extremely stressful. At the VA Maryland Health Care ... who care for veterans patients. “Caregivers have a difficult job. Seventy-four percent ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... (Meso Foundation) released information for caregivers and held two webinars on topics of ... on demand free of charge at . , With a loved ...
(Date:11/30/2015)... ... 30, 2015 , ... According to research by the National ... technicians to be certified or obtain continuing education. To increase awareness of the ... Mouth?” campaign to inform dentists that the technicians they trust could lack the ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... . The directory is specialized and only includes chiropractic clinics in the ... a competent and trustworthy alternative health practitioner when back pain sets in. When ...
(Date:11/30/2015)... ... 30, 2015 , ... The Museum of Science & Industry ... new era of publicly accessible automated technology. Now, by popular demand, the Meridian ... an up-close look at the shuttle at MOSI’s main entrance. This experience continues ...
Breaking Medicine News(10 mins):